AU2023404553A1 - Polypeptide inhibitor, and preparation method therefor and use thereof - Google Patents
Polypeptide inhibitor, and preparation method therefor and use thereof Download PDFInfo
- Publication number
- AU2023404553A1 AU2023404553A1 AU2023404553A AU2023404553A AU2023404553A1 AU 2023404553 A1 AU2023404553 A1 AU 2023404553A1 AU 2023404553 A AU2023404553 A AU 2023404553A AU 2023404553 A AU2023404553 A AU 2023404553A AU 2023404553 A1 AU2023404553 A1 AU 2023404553A1
- Authority
- AU
- Australia
- Prior art keywords
- alkyl
- amino acid
- acid
- amino
- cooh
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Analytical Chemistry (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211530438.1 | 2022-11-30 | ||
| CN202211530438 | 2022-11-30 | ||
| CN202310206299.5 | 2023-03-03 | ||
| CN202310206299 | 2023-03-03 | ||
| CN202310261818.8 | 2023-03-15 | ||
| CN202310261818 | 2023-03-15 | ||
| CN202310349519.X | 2023-03-31 | ||
| CN202310349519 | 2023-03-31 | ||
| CN202311144489.5 | 2023-09-05 | ||
| CN202311144489 | 2023-09-05 | ||
| PCT/CN2023/135637 WO2024114762A1 (zh) | 2022-11-30 | 2023-11-30 | 一种多肽抑制剂、其制备方法和应用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2023404553A1 true AU2023404553A1 (en) | 2025-07-10 |
Family
ID=91323029
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2023404553A Pending AU2023404553A1 (en) | 2022-11-30 | 2023-11-30 | Polypeptide inhibitor, and preparation method therefor and use thereof |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20260193294A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4628499A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025540765A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20250111134A (cg-RX-API-DMAC7.html) |
| CN (1) | CN120202212A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023404553A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL321139A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2025006152A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202440611A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2024114762A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025242221A1 (zh) * | 2024-05-24 | 2025-11-27 | 上海翰森生物医药科技有限公司 | 新型修饰侧链、其制备方法和应用 |
| WO2026013260A1 (en) | 2024-07-12 | 2026-01-15 | Zealand Pharma A/S | Peptide inhibitors of interleukin-23 receptor |
| WO2026052109A1 (zh) * | 2024-09-06 | 2026-03-12 | 上海翰森生物医药科技有限公司 | 一种多肽抑制剂的药物组合物及其用途 |
| WO2026057052A1 (zh) * | 2024-09-14 | 2026-03-19 | 深圳信立泰药业股份有限公司 | 一种il-23受体抑制剂及其制备方法和用途 |
| WO2026138829A1 (zh) * | 2024-12-23 | 2026-07-02 | 上海医药集团股份有限公司 | 多肽抑制剂及其应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10201810154WA (en) * | 2014-07-17 | 2018-12-28 | Protagonist Therapeutics Inc | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases |
| EP4021919A1 (en) | 2019-08-30 | 2022-07-06 | Merck Sharp & Dohme Corp. | Pcsk9 antagonist compounds |
| US12577259B2 (en) | 2019-12-20 | 2026-03-17 | Merck Sharp & Dohme Llc | PCSK9 antagonist compounds |
| MX2022008740A (es) * | 2020-01-15 | 2022-09-23 | Janssen Biotech Inc | Peptidos inhibidores del receptor de interleucina-23 y su uso para tratar enfermedades inflamatorias. |
| SMT202500254T1 (it) * | 2020-01-15 | 2025-09-12 | Janssen Biotech Inc | Inibitori peptidici del recettore dell'interleuchina-23 e loro uso per trattare malattie infiammatorie |
| AU2021383828A1 (en) * | 2020-11-20 | 2023-07-06 | Janssen Pharmaceutica Nv | Compositions of peptide inhibitors of interleukin-23 receptor |
-
2023
- 2023-11-30 WO PCT/CN2023/135637 patent/WO2024114762A1/zh not_active Ceased
- 2023-11-30 AU AU2023404553A patent/AU2023404553A1/en active Pending
- 2023-11-30 US US19/133,875 patent/US20260193294A1/en active Pending
- 2023-11-30 KR KR1020257019116A patent/KR20250111134A/ko active Pending
- 2023-11-30 TW TW112146695A patent/TW202440611A/zh unknown
- 2023-11-30 JP JP2025531331A patent/JP2025540765A/ja active Pending
- 2023-11-30 IL IL321139A patent/IL321139A/en unknown
- 2023-11-30 CN CN202380079192.7A patent/CN120202212A/zh active Pending
- 2023-11-30 EP EP23896904.2A patent/EP4628499A1/en active Pending
-
2025
- 2025-05-27 MX MX2025006152A patent/MX2025006152A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL321139A (en) | 2025-07-01 |
| JP2025540765A (ja) | 2025-12-16 |
| MX2025006152A (es) | 2025-07-01 |
| CN120202212A (zh) | 2025-06-24 |
| US20260193294A1 (en) | 2026-07-09 |
| TW202440611A (zh) | 2024-10-16 |
| WO2024114762A1 (zh) | 2024-06-06 |
| KR20250111134A (ko) | 2025-07-22 |
| EP4628499A1 (en) | 2025-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4628499A1 (en) | Polypeptide inhibitor, and preparation method therefor and use thereof | |
| JP7460541B2 (ja) | アシネトバクター・バウマンニ(Acinetobacter baumannii)に対するペプチド大環状分子 | |
| CA2922607C (en) | 1,2,4-oxadiazole derivatives as immunomodulators | |
| KR100648578B1 (ko) | α-케토아미드 다촉매활성의 프로테아제 억제제 | |
| CA3237911A1 (en) | Method for producing n-alkyl amino acid and peptide including n-alkyl amino acid | |
| CN101279955B (zh) | 作为二肽肽激酶-iv抑制剂的n-取代硫吗啉衍生物及其医药用途 | |
| CA3135024A1 (en) | Methods for synthesizing .beta.-homoamino acids | |
| US7265146B2 (en) | Integrin receptor inhibitors | |
| JP7746628B1 (ja) | Tnf受容体1活性を阻害するための環状ペプチド | |
| CN115190762B (zh) | 新的取代的磺酰脲和磺酰亚胺脲衍生物 | |
| JP2022515720A (ja) | Il-17に特異的な二環式ペプチドリガンド | |
| CN105658670A (zh) | 肽-低聚尿素嵌合化合物及其使用方法 | |
| AU2022356942A1 (en) | Tricyclic polypeptide conjugated drug and use thereof | |
| JP2020500907A (ja) | 細胞外クエン酸の取込みの阻害剤としてのスルホンアミド | |
| EP0153720A2 (en) | Spergualin-related compounds having a phenylene group, a process for their preparation and their use as medicaments | |
| US11866518B2 (en) | Bicyclic peptide ligands specific for TSLP | |
| KR20220124742A (ko) | 표적화된 스테로이드 화합물 | |
| AU2022328932A1 (en) | Polypeptide drug conjugate having novel structure and application thereof | |
| JP4927566B2 (ja) | Par−2アゴニスト | |
| JPH02131458A (ja) | 新スパガリン関連化合物、その製造法及びその用途 | |
| KR20160111846A (ko) | 흉선 기질 림프단백질 매개 신호전달을 제어하는 펩타이드 유도체 및 이를 포함하는 알러지 및 천식 질환 예방 및 치료용 약학 조성물 | |
| JP4842254B2 (ja) | Par−2アゴニスト | |
| JP2003518085A (ja) | Cd45阻害剤 | |
| CN116082182A (zh) | 秋水仙碱衍生物的制备方法及其用途 | |
| WO2026057052A1 (zh) | 一种il-23受体抑制剂及其制备方法和用途 |